Inventor · disambiguated record
Abraham Anderson
Also filed as: ANDERSON ABRAHAM · ANDERSON ABRAHAM ANTONIO
8 granted patents·4 pending applications·114 citations·filing 1998–2025
87Inventor score
Top patents by PatentIndex Score
12 records- 0188US8465741B2Antibodies and methods for making and using themFREY GERHARD·Filed 2007·Granted Jun 18, 2013·11 cites·8 claims
- 0276US8945550B2Antibodies and methods for making and using themFREY GERHARD·Filed 2009·Granted Feb 3, 2015·2 cites·4 claims
- 0376US8168201B2VaccinesHICKLE LESLIE·Filed 2007·Granted May 1, 2012·3 cites·24 claims
- 0475US6415453B1Low temperature thermal insulation garment utilizing the wearer's exhalantANDERSON ABRAHAM·Filed 2001·Granted Jul 9, 2002·39 cites·5 claims
- 0573US2025345377A1Biomarkers for cancer therapeuticsMERCK SHARP & DOHME·Filed 2025·Application pending·0 cites
- 0669US9151761B2Predictive biomarker of survival in the treatment of renal cell carcinomaANDERSON ABRAHAM ANTONIO·Filed 2012·Granted Oct 6, 2015·4 cites·22 claims
- 0763US12310999B2Biomarkers for cancer therapeuticsMERCK SHARP & DOHME·Filed 2018·Granted May 27, 2025·0 cites·18 claims
- 0854US2013287766A1Antibodies and methods for making and using themMMRGLOBAL INC·Filed 2013·Application pending·0 cites
- 0939US2014234328A1Use of c-met protein for predicting the efficacy of anti-hepatocyte growth factor ("hgf") antibodies in esophageal and gastric cancer patientsANDERSON ABRAHAM·Filed 2012·Application pending·0 cites
- 1037US6148825AMethod of using a dedicated internal shunt and stent for the inferior vena cavaFiled 1998·Granted Nov 21, 2000·34 cites·6 claims
- 1137US2019004048A1Biomarker of Survival in the Treatment of Renal Cell Carcinoma with a VEGFR Inhibitor and an Ang2 InhibitorAMGEN INC·Filed 2016·Application pending·0 cites
- 1232US6325776B1Internal by-pass shunt apparatus for the inferior vena cavaFiled 1999·Granted Dec 4, 2001·21 cites·22 claims
Join the waitlist — get patent alerts
Get an alert when Abraham Anderson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →